Company / Shares Outstanding
Protalix BioTherapeutics, Inc. Shares Outstanding History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
75.9M
FY2025
5-year range
34.8M / 75.9M
FY2021-FY2025
Trend
+4.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 5 consecutive years, from 14838213.00 in FY2020 to 75850275.00 in FY2025.
Based on SEC 10-K filings.
75850275.00 in FY2025 with a 10-year CAGR of -2.1%.
Increased from 53790167.00 to 75850275.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +18.5%
- 5-Year CAGR
- +38.6%
- 10-Year CAGR
- -2.1%
Key checks
Key Insights
- Protalix BioTherapeutics, Inc.'s shares outstanding has grown for 5 consecutive years.
- In FY2025, shares outstanding increased 4.0% year-over-year.
- Peak shares outstanding was recorded in FY2017.
- Lowest shares outstanding in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 75.9M | +4.0% |
| FY2024 | 73.0M | +35.6% |
| FY2023 | 53.8M | +18.1% |
| FY2022 | 45.6M | +31.0% |
| FY2021 | 34.8M | +134.3% |
| FY2020 | 14.8M | +0.0% |
| FY2019 | 14.8M | -88.0% |
| FY2017 | 124.1M | +24.4% |
| FY2016 | 99.8M | +6.6% |
| FY2015 | 93.6M | +0.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026